In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical ...

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.

purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services ...

Thermo Fisher Scientific posted a modest decline in third-quarter net income, but boosted the lower end of its projected range for 2024 operating earnings on steady sales of laboratory equipment.

Shares of Thermo Fisher Scientific Inc. TMO rallied 1.30% to $599.25 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average ...

Thermo Fisher Scientific Inc. (NYSE: TMO) delivers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab ...

(a) Adjusted results in 2024 and 2023 exclude charges for inventory write-downs associated with large-scale abandonment of product lines, accelerated depreciation on manufacturing assets to be ...

Thermo Fisher Scientific Inc. has notified the state that it plans to lay off employees at two Massachusetts sites and close a third entirely.

"Thermo Fisher’s Oncomine gains FDA approval as brain tumor diagnostic" was originally created and published by Medical ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cas ...